Generation and characterization of an inducible transgenic model for studying mouse esophageal biology

BMC Developmental Biology

Riccardo Fodde²  John Kong a San¹  Kim Monkhorst²  Patrick Franken²  Sabrina Roth² 

[1] Department of Cell Biology, Erasmus MC, Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands;Department of Pathology, Josephine Nefkens Institute, PO Box 2040, 3000 CA, Rotterdam, The Netherlands

关键词: Doxycycline inducible;    ED-L2;    Promoter;    Turnover rate;    Esophagus;    Mouse;   

Others  :  1086592
DOI  :  10.1186/1471-213X-12-18

 received in 2011-11-21, accepted in 2012-05-22,  发布年份 2012

【 摘 要 】

Background

To facilitate the in vivo study of esophageal (stem) cell biology in homeostasis and cancer, novel mouse models are necessary to elicit expression of candidate genes in a tissue-specific and inducible fashion. To this aim, we developed and studied a mouse model to allow labeling of esophageal cells with the histone 2B-GFP (H2B-GFP) fusion protein.

Results

First, we generated a transgenic mouse model expressing the reverse tetracycline transactivator rtTA2-M2 under control of the promoter (ED-L2) of the Epstein-Barr virus (EBV) gene encoding the latent membrane protein-1 (LMP-1). The newly generated ED-L2-rtTA2-M2 (ED-L2-rtTA) mice were then bred with the previously developed tetO-HIST1H2BJ/GFP (tetO-H2B-GFP) model to assess inducibility and tissue-specificity. Expression of the H2B-GFP fusion protein was observed upon doxycycline induction but was restricted to the terminally differentiated cells above the basal cell layer. To achieve expression in the basal compartment of the esophagus, we subsequently employed a different transgenic model expressing the reverse transactivator rtTA2S-M2 under the control of the ubiquitous, methylation-free CpG island of the human hnRNPA2B1-CBX3 gene (hnRNP-rtTA). Upon doxycycline administration to the compound hnRNP-rtTA/tetO-H2B-GFP mice, near-complete labeling of all esophageal cells was achieved. Pulse-chase experiments confirmed that complete turnover of the esophageal epithelium in the adult mouse is achieved within 7–10 days.

Conclusions

We show that the esophagus-specific promoter ED-L2 is expressed only in the differentiated cells above the basal layer. Moreover, we confirmed that esophageal turn-over in the adult mouse does not exceed 7–10 days.

【 授权许可】

   
2012 Roth et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Leblond CP: Classification of Cell Populations on the Basis of Their Proliferative Behavior. Natl Cancer Inst Monogr 1964, 14:119-150.
• [2]Seery JP, Watt FM: Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol 2000, 10:1447-1450.
• [3]Kalabis J, Oyama K, Okawa T, Nakagawa H, Michaylira CZ, Stairs DB, Figueiredo JL, Mahmood U, Diehl JA, Herlyn M, Rustgi AK: A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. J Clin Invest 2008, 118:3860-3869.
• [4]Seery JP: Stem cells of the oesophageal epithelium. J Cell Sci 2002, 115:1783-1789.
• [5]Shaheen NJ: Advances in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology 2005, 128:1554-1566.
• [6]Spechler SJ, Goyal RK: The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996, 110:614-621.
• [7]Roth S, Franken P, van Veelen W, Blonden L, Raghoebir L, Beverloo B, van Drunen E, Kuipers EJ, Rottier R, Fodde R, Smits R: Generation of a tightly regulated doxycycline-inducible model for studying mouse intestinal biology. Genesis 2009, 47:7-13.
• [8]Wilson JB, Weinberg W, Johnson R, Yuspa S, Levine AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990, 61:1315-1327.
• [9]Nakagawa H, Wang TC, Zukerberg L, Odze R, Togawa K, May GH, Wilson J, Rustgi AK: The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 1997, 14:1185-1190.
• [10]Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W: Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A 2000, 97:7963-7968.
• [11]Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E: Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363.
• [12]Katsantoni EZ, Anghelescu NE, Rottier R, Moerland M, Antoniou M, de Crom R, Grosveld F, Strouboulis J: Ubiquitous expression of the rtTA2S-M2 inducible system in transgenic mice driven by the human hnRNPA2B1/CBX3 CpG island. BMC Dev Biol 2007, 7:108. BioMed Central Full Text
• [13]Bell B, Almy TP, Lipkin M: Cell proliferation kinetics in the gastrointestinal tract of man. 3. Cell renewal in esophagus, stomach, and jejunum of a patient with treated pernicious anemia. J Natl Cancer Inst 1967, 38:615-628.
• [14]Goldstein BG, Chao HH, Yang Y, Yermolina YA, Tobias JW, Katz JP: Overexpression of Kruppel-like factor 5 in esophageal epithelia in vivo leads to increased proliferation in basal but not suprabasal cells. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1784-G1792.
• [15]Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.